Citation: Ah. Amsden et K. Suzumura, An interview with Miyohei Shinohara: Nonconformism in Japanese economic thought, J JPN INT E, 15(3), 2001, pp. 341-360
Authors:
Tanaka, K
Yasuhara, M
Suzumura, K
Narita, H
Suzuki, T
Citation: K. Tanaka et al., Effects of fluvastatin and its major metabolites on low-density lipoprotein oxidation and cholesterol esterification in macrophages, JPN J PHARM, 86(3), 2001, pp. 289-296
Authors:
Tanaka, Y
Funahashi, H
Imai, T
Naruse, T
Suzumura, K
Oda, Y
Citation: Y. Tanaka et al., The effectiveness of administering a minimal dose of octreotide long-term prior to surgery for insulinoma: Report of a case, SURG TODAY, 30(6), 2000, pp. 541-543
Authors:
Suzumura, K
Tanaka, K
Yasuhara, M
Narita, H
Citation: K. Suzumura et al., Inhibitory effects of fluvastatin and its metabolites on hydrogen peroxide-induced oxidative destruction of hemin and low-density lipoprotein, BIOL PHAR B, 23(7), 2000, pp. 873-878
Authors:
Yasuhara, M
Suzumura, K
Tanaka, K
Takahashi, M
Aoki, S
Odawara, A
Narita, H
Suzuki, T
Citation: M. Yasuhara et al., Fluvastatin, an HMG-CoA reductase inhibitor, protects LDL from oxidative modification in hypercholesterolemic rabbits, BIOL PHAR B, 23(5), 2000, pp. 570-574
Authors:
Suzumura, K
Kasahara, E
Ohnishi, Y
Chien, KC
Inoue, M
Citation: K. Suzumura et al., Fluvastatin normalizes the decreased turnovers of glutathione and ascorbicacid in watanabe heritable hyperlipidaemic rabbits, CLIN EXP PH, 27(9), 2000, pp. 709-714
Authors:
Suzumura, K
Kasahara, E
Wang, Y
Chien, KC
Inoue, M
Citation: K. Suzumura et al., Decreased turnovers of glutathione and ascorbic acid in watanabe heritablehyperlipidemic rabbits, J NUTR SC V, 46(4), 2000, pp. 205-209
Authors:
Taniguchi, M
Watanabe, M
Nagai, K
Suzumura, K
Suzuki, K
Tanaka, A
Citation: M. Taniguchi et al., gamma-pyrone compounds with selective and potent anti-Helicobacter pylori activity, J ANTIBIOT, 53(8), 2000, pp. 844-847
Authors:
Doi, H
Kaburaki, M
Inoue, H
Suzumura, K
Narita, H
Citation: H. Doi et al., Protective effect of TA-993, a novel therapeutic agent for peripheral circulatory insufficiency, on skeletal muscle fatigue in a rat model of hindlimb ischemia, JPN J PHARM, 83(1), 2000, pp. 73-81
Authors:
Suzumura, K
Warashina, M
Yoshinari, K
Tanaka, Y
Kuwabara, T
Orita, M
Taira, K
Citation: K. Suzumura et al., Significant change in the structure of a ribozyme upon introduction of a phosphorothioate linkage at P9: NMR reveals a conformational fluctuation in the core region of a hammerhead ribozyme, FEBS LETTER, 473(1), 2000, pp. 106-112
Authors:
Suzumura, K
Odawara, A
Yasuhara, M
Tanaka, K
Narita, H
Suzuki, T
Citation: K. Suzumura et al., In vitro inhibitory effects of the optical isomers and metabolites of fluvastatin on copper ion-induced LDL oxidation, BIOL PHAR B, 22(9), 1999, pp. 971-974
Citation: K. Suzumura et Y. Yasaki, Competition and regulation in telecommunications: Japan's reform experience since 1985, HITO J ECON, 40(1), 1999, pp. 1-28
Authors:
Suzumura, K
Yasuhara, M
Tanaka, K
Odawara, A
Narita, H
Suzuki, T
Citation: K. Suzumura et al., An in vitro study of the hydroxyl radical scavenging-property of fluvastatin, an HMG-CoA reductase inhibitor, CHEM PHARM, 47(7), 1999, pp. 1010-1012
Authors:
Suzumura, K
Yasuhara, M
Tanaka, K
Suzuki, T
Citation: K. Suzumura et al., Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitor, on oxidative modificationof human low-density lipoprotein in vitro, BIOCH PHARM, 57(6), 1999, pp. 697-703